The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
EB

e.bakken

TL2 Moderator · Beirut

Contributes reviews on supplier material. Based in Beirut.

Joined 3 April 2025 · last posted 7d

93Posts here
1Topics
1Solutions
489Likes received
672Likes given
20Badges
155Days visited
2.1kPosts read

Most-liked posts

  • About the North America category Replied, post #7 · Regional › North America · 16 Oct 2025 · 31 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
  • Biased agonism: a real phenomenon, an over-used explanation Replied, post #59 · Pharmacology › Receptor biology · 8 Mar 2025 · 29 likes Coming back to post #57, because the follow-up matters more than the original answer. Cross-reactivity and selectivity: the compounds are not perfectly selective for…
  • Journal club: orforglipron phase 2 and the non-peptide question Replied, post #49 · Evidence › Journal club · 27 Apr 2026 · 28 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
  • A preprint whose numbers changed substantially at publication Replied, post #27 · Evidence › Preprints · 22 Aug 2025 · 28 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
  • Promotion criteria, and the one that stops most nominations Replied, post #129 · Documentation › Doc review · 2 Dec 2024 · 28 likes post #128 answers the question as asked. The question underneath it is different. Review date disputes: if a maintained page's review date is approaching and it has not…
  • Reading a home test result without over-claiming Replied, post #7 · Analytics › Home & field testing · 7 Apr 2026 · 26 likes On post #3 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…

Where this member posts

CategoryPostsShare
Analytics1415%
Practice1213%
Sourcing910%
Access910%
Evidence89%
Start Here66%

Badges earned, in order

BadgeTierGranted
Basic Userbronze6 Apr 2025
Read the Guidelinesbronze8 Apr 2025
First Replybronze11 Apr 2025
Welcomebronze13 Apr 2025
First Topicbronze16 Apr 2025
First Linkbronze25 Apr 2025
First Quotebronze26 Apr 2025
Asked Wellbronze30 Apr 2025
First Tagbronze4 May 2025
Generousbronze22 May 2025
Memberbronze27 May 2025
Sourcedbronze1 Jul 2025
Thank Yousilver3 Jul 2025
First Solutionbronze4 Jul 2025
Good Postsilver7 Jul 2025
Editorbronze15 Jul 2025
Readerbronze23 Jul 2025
Nice Postbronze23 Aug 2025
Anniversarysilver3 Apr 2026
De-escalatorgold8 Jun 2026